Clinical Trial Search Results for "EARLY ACS-TIMI 39"

Giugliano, R. P., Newby, L. K., Harrington, R. A., Gibson, C. M., Van de Werf, F., Armstrong, P., Montalescot, G., Gilbert, J., Strony, J. T., Califf, R. M., Braunwald, E. The early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation acute coronary syndrome (EARLY ACS) trial: a randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non-ST-segment elevation acute coronary syndrome--study design and rationale Am Heart J. 2005;149(6):994-1002. Abstract

Giugliano, R. P., White, J. A., Bode, C., Armstrong, P. W., Montalescot, G., Lewis, B. S., van 't Hof, A., Berdan, L. G., Lee, K. L., Strony, J. T., Hildemann, S., Veltri, E., Van de Werf, F., Braunwald, E., Harrington, R. A., Califf, R. M., Newby, L. K. Early versus delayed, provisional eptifibatide in acute coronary syndromes N Engl J Med. 2009;360(21):2176-90. Abstract

Melloni, C., James, S. K., White, J. A., Giugliano, R. P., Harrington, R. A., Huber, K., Tricoci, P., Armstrong, P. W., Van de Werf, F., Montalescot, G., Califf, R. M., Newby, L. K., Early ACS Investigators Safety and efficacy of adjusted-dose eptifibatide in patients with acute coronary syndromes and reduced renal function. Am Heart J. 2011;162(5):884-892. Abstract

Toleva O, Westerhout CM, Senaratne M, Bode C, Lindroos M, Ardissino D, Sulimov VA, Montalescot G, Newby LK, Giugliano RP, Van de Werf F, Armstrong PW Association of Hub and Spoke Practice Patterns with Coronary Interventino and Outcomes in Non ST Elevation Acute Coronary Syndromes (NSTE ACS): Insights from the Early Glycoprotein IIb/IIIa Inhibition in NSTE ACS (EARLY-ACS) Trial J Am Coll Cardiol. 2011;57(14):74.

Lopes, R. D., White, J. A., Tricoci, P., White, H. D., Armstrong, P. W., Braunwald, E., Giugliano, R. P., Harrington, R. A., Lewis, B. S., Brogan, G. X., Jr., Gibson, C. M., Califf, R. M., Newby, L. K. Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: Insights from the EARLY ACS trial International journal of cardiology. 2012;NA(NA):NA. Abstract

Piccini, J. P., White, J. A., Mehta, R. H., Lokhnygina, Y., Al-Khatib, S. M., Tricoci, P., Pollack, C. V., Jr., Montalescot, G., Van de Werf, F., Gibson, C. M., Giugliano, R. P., Califf, R. M., Harrington, R. A., Newby, L. K. Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes Circulation. 2012;126(1):41-9. Abstract

Roe, M. T., White, J. A., Kaul, P., Tricoci, P., Lokhnygina, Y., Miller, C. D., van't Hof, A. W., Montalescot, G., James, S. K., Saucedo, J., Ohman, E. M., Pollack, C. V., Jr., Hochman, J. S., Armstrong, P. W., Giugliano, R. P., Harrington, R. A., Van de Werf, F., Califf, R. M., Newby, L. K. Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: insights from the EARLY ACS Trial Circ Cardiovasc Qual Outcomes. 2012;5(2):205-13. Abstract

Bagai, A., White, J. A., Lokhnygina, Y., Giugliano, R. P., Van de Werf, F., Montalescot, G., Armstrong, P. W., Tricoci, P., Gibson, C. M., Califf, R. M., Harrington, R. A., Newby, L. K. Routine early eptifibatide versus delayed provisional use at percutaneous coronary intervention in high-risk non-ST-segment elevation acute coronary syndromes patients: An analysis from the Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome trial Am Heart J. 2013;166(3):466-473 e1. Abstract

Giraldez, R. R., Clare, R. M., Lopes, R. D., Dalby, A. J., Prabhakaran, D., Brogan, G. X., Jr., Giugliano, R. P., James, S. K., Tanguay, J. F., Pollack, C. V., Jr., Harrington, R. A., Braunwald, E., Newby, L. K. Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndrome Am Heart J. 2013;165(6):918-925 e2. Abstract

Kaul, P., Tanguay, J. F., Newby, L. K., Hochman, J. S., Westerhout, C. M., Califf, R. M., Tricoci, P., Gibson, C. M., Giugliano, R. P., Harrington, R. A., Van de Werf, F., Armstrong, P. W. Association between bleeding and mortality among women and men with high-risk acute coronary syndromes: insights from the Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes (EARLY ACS) trial Am Heart J. 2013;166(4):723-8. Abstract

Tricoci, P., Leonardi, S., White, J., White, H. D., Armstrong, P. W., Montalescot, G., Giugliano, R. P., Gibson, C. M., Van de Werf, F., Califf, R. M., Harrington, R. A., Braunwald, E., Mahaffey, K. W., Newby, L. K. Cardiac Troponin after Percutaneous Coronary Intervention and 1-Year Mortality in NSTE ACS Using Systematic Evaluation of Biomarker Trends J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Kunadian, V., Giugliano, R. P., Newby, L. K., Zorkun, C., Guo, J., Bagai, A., Montalescot, G., Braunwald, E., Califf, R. M., Van de Werf, F., Armstrong, P. W., Harrington, R., Gibson, C. M. Angiographic Outcomes With Early Eptifibatide Therapy in Non-ST-Segment Elevation Acute Coronary Syndrome (from the EARLY ACS Trial) Am J Cardiol. 2014;113(8):1297-305. Abstract